Clinical Trial Update: Clinical Safety and Scar Prevention Study of a Topical Antifibrotic Compound FS2. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating safety and scar prevention with topical antifibrotic compound FS2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cicatrix
• Donor Site Complications
• Hypertrophic Scar
• Keloid
• Scar
• Skin Graft Complications
• Skin Graft Scar

Drugs mentioned

• FS2

Snippet

Sponsor: University of British Columbia | Conditions: Scar, Cicatrix | Phase 2 | Status: UNKNOWN